Gemzar and Hemolytic uremic syndrome
Result of checking the interaction of drug Gemzar and disease Hemolytic uremic syndrome for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:Hemolytic uremic syndrome (HUS), including fatalities from renal failure or the requirement for dialysis can occur in patients treated with gemcitabine. Renal function should be assessed prior to treatment initiation. Gemcitabine should be permanently discontinued in patients with HUS or severe renal impairment. Renal failure may not be reversible even with discontinuation of therapy.
- "Product Information. Gemzar (gemcitabine)." Lilly, Eli and Company, Indianapolis, IN.